Breaking News Today

Steroids confirmed to help severely ill coronavirus patients

Published: (Updated: ) in Australian News by .

New studies confirm that multiple types of steroids improve survival for severely ill COVID-19 patients, cementing the cheap drugs as a standard of care.

New studies confirm that multiple types of steroids improve survival for severely ill COVID-19 patients, cementing the cheap drugs as a standard of care.

An analysis of pooled results from seven studies, led by the World Health Organisation and published overnight by the Journal of the American Medical Association, found that steroids reduced the risk of death in the first month by about one-third compared to placebo treatment or usual care alone in these seriously ill patients who needed extra oxygen.

READ MORE: COVID-19 myths and misconceptions busted by WHO

"This result opens up more choices" of steroids, said Dr Martin Landray of the University of Oxford, who led one of the studies.

"The more options there are in terms of availability, the better."

Dr Anthony Gordon of Imperial College London called the result "a huge step forward", but added, "as impressive as these results are, it's not a cure".

Steroid drugs are inexpensive, widely available and have been used for decades. They reduce inflammation, which sometimes develops in coronavirus patients as the immune system overreacts to fight the infection. This overreaction damages the lungs and can prove fatal. These drugs are not the same type of steroids that are used or misused for athletic performance.

In June, a large study led by the University of Oxford found that a steroid called dexamethasone cut deaths by up to 35 per cent in hospitalised COVID-19 patients who needed treatment with breathing machines and by 20 per cent in those only needing extra oxygen. It did not help less sick patients and might even have even been harmful at that stage of illness.

READ:  Giant shark was even bigger than we thought, researchers say

READ MORE: Everything you need to know about the Oxford University coronavirus vaccine

The results changed care immediately and prompted many other studies that were testing steroids to stop, so more people could be given the drug. The new analysis looked at results from six of those studies that were stopped early plus severe patients in the Oxford study to see if all types of steroids were similarly effective, and concluded they are.

There were 222 deaths among the 678 patients given a steroid and 425 deaths among the 1025 patients given placebos or just usual care.

"I'm delighted," said Dr Derek Angus, critical care chief at the University of Pittsburgh Medical Centre, who helped lead one of the studies.

"It's incredibly reassuring that the other trials all were lining up in the same direction. It's the most solid news we've had yet on how to take care of patients with COVID-19."

READ MORE: How 'long covid' leaves survivors facing strange and frightening futures

Mark Shannon, a 61-year-old retired bank teller from Pittsburgh who spent 11 days on a breathing machine, received the steroid hydrocortisone in the study and recovered. His doctor told him "that was pretty stupendous" to recover from so long on a ventilator, he said.

"I realise how close I came to losing my life," he said.

Treatment guidelines in the US now recommend dexamethasone or others only when it's not available for hospitalised COVID-19 patients needing extra oxygen, but that could change with the new information.

– Reported with Associated Press

You can get up-to-date information from the Federal Government's Coronavirus Australia app, available on the App Store, Google Play and the Government's WhatsApp channel.

Beyond Blue's Coronavirus Mental Wellbeing Support Service is a 24/7 service free of charge to all Australians. Visit the site here or call 1800 512 348.

For coronavirus breaking news alerts and livestreams straight to your smartphone sign up to the 9News app and set notifications to on at the App Store or Google Play.

Source: 9News

READ:  'It's negligent: Plea for more specialist nurses for patients with Australia's deadliest cancer

Share This
Finance Advice 2021